APLS — Apellis Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Apellis Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	352	878	701	552	351
Net Total Accounts Receivable
Net Total Receivables	—	—	10.1	29.2	224
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	373	917	824	720	766
Net Property, Plant And Equipment	15.8	24.5	26.1	24.9	21.1
Other Long Term Assets
Total Assets	389	961	882	760	789
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	65.8	128	132	168	248
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	355	756	683	590	594
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	34.2	205	199	170	195
Total Liabilities & Shareholders' Equity	389	961	882	760	789
Total Common Shares Outstanding